Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the Oropharynx
Mark R. Waddle(Mayo Clinic), Robert C. Miller(Mayo Clinic), Eric J. Moore(Mayo Clinic), Darlene E. Graner(Mayo Clinic in Arizona), Samir H. Patel(WinnMed), Jeffrey R. Janus(Mayo Clinic in Arizona), Joaquín J. García(Mayo Clinic), Katherine A. Price(Mayo Clinic), Christopher L. Hallemeier(Mayo Clinic in Arizona), Bijan J. Borah(Mayo Clinic in Florida), J. Daniel(Mayo Clinic), M.A. Neben-Wittich(Mayo Clinic), Jan L. Kasperbauer(Mayo Clinic), Ashish V. Chintakuntlawar(Mayo Clinic Hospital), Jackson May(Mayo Clinic in Arizona), Daniel L. Price(Mayo Clinic in Arizona), Robert L. Foote(Mayo Clinic), Yolanda I. Garces(Mayo Clinic), Michael L. Hinni(Mayo Clinic), Sue L. Visscher(Mayo Clinic)
International Journal of Radiation Oncology*Biology*Physics
December 23, 2020
Cited by 7
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
|Thyroid|2021|699
Estimating Survival in Patients With Lung Cancer and Brain Metastases
|JAMA Oncology|2016|655
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
|Journal of the National Comprehensive Cancer Network|2018|632